AlphaMol Founder Named a Clarivate Highly Cited Researcher 2026
From · AlphaMol
The cofounder of AlphaMol Dr. Shuguang Yuan, has received official notification from Clarivate of his selection to the Highly Cited Researchers 2026 list. The annual program recognizes scientists and social scientists whose work has demonstrated significant and broad influence in their fields.
According to Clarivate’s selection framework, each named researcher has authored multiple Highly Cited Papers ranking in the top 1% by citations for their field and publication year within an 11-year assessment window. Citation data form the foundation of the assessment, which is further refined through additional quantitative indicators and qualitative expert review.
Dr. Yuan’s scientific work spans G protein-coupled receptor (GPCR) structure and function, molecular simulation, computer-aided drug discovery, and related interdisciplinary approaches.The recognition highlights the international academic reach of research in these interconnected areas.
Earlier in 2026, Dr. Yuan also received a Top Cited Scholar 2026 certificate from Scilit. The Scilit and Clarivate distinctions are independently assessed programs, each reflecting research influence through its own criteria.
AlphaMol remains committed to rigorous basic research, scientific collaboration, and the translation of advances in computational science and GPCR biology into innovative drug-discovery programs.